Results 181 to 190 of about 3,370,595 (309)
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed+8 more
wiley +1 more source
Fast and accurate short-read alignment with hybrid hash-tree data structure. [PDF]
Makino J+3 more
europepmc +1 more source
Physical and data structure of 3D genome. [PDF]
Huang K+9 more
europepmc +1 more source
Feasibility of a set-theoretic data structure : a general structure based on a reconstituted definition of relation [PDF]
David L. Childs
openalex
Comprehensive cancer centre (CCCs) and CCCs of Excellence (CCCoE) integration in healthcare. Through outreach to surrounding community hospitals, CCCs enable wider access to top‐clinical cancer treatments and care, thereby facilitating the swift enrolment of patients into data‐rich clinical trials (PI‐initiated trials testing new concepts, drug ...
Anton Berns+4 more
wiley +1 more source
Comprehensive encoding of conformational and compositional protein structural ensembles through the mmCIF data structure. [PDF]
Wankowicz SA, Fraser JS.
europepmc +1 more source
Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma
The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias+12 more
wiley +1 more source
The past, present, and future of the brain imaging data structure (BIDS). [PDF]
Poldrack RA+114 more
europepmc +1 more source